Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...

Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

Novo Nordisk A/S NVO plans to start selling its blockbuster obesity drug Wegovy in vials, marking its latest effort to ...

Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug.

The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of injectable versions, healthcare analytics firm Truveta suggests.

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

New data shows Wegovy pill uptake: 36% are new to GLP-1s, with many switching from injectable versions. Read more here.

Read more about More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds on Devdiscourse ...